Baidu
map

Radiology:超声衰减成像在非酒精性脂肪性肝炎诊断中的应用

2022-09-17 shaosai MedSci原创

非酒精性脂肪肝的肝脏疾病谱从简单的脂肪变性到肝硬化,其中包括非酒精性脂肪性肝炎(NASH),其特点是脂肪变性、肝小叶炎症和肝细胞气球样变。

众所周知非酒精性脂肪肝(NAFLD)是肝脏疾病最重要的原因之一,严重时会导致终末期肝病。非酒精性脂肪肝的肝脏疾病谱从简单的脂肪变性到肝硬化,其中包括非酒精性脂肪性肝炎(NASH),其特点是脂肪变性、小叶炎症和肝细胞气球样变

为了对非酒精性脂肪肝进行更准确、更少的侵入性诊断过去十年中,许多研究对US和MRI的使用进行了评估。最近,一些单中心和回顾性研究表明,与肝脏活检相比,使用衰减成像(ATI)和二维(2D)剪切波弹性成像(SWE)可以同时评估代表NASH病理成分的脂肪变性、炎症和纤维化,具有显著的准确性。根据这些研究,用ATI获得的衰减系数(AC)在检测不同程度的肝脏脂肪变性方面显示出良好的诊断性能。此外,使用二维SWE获得的肝脏硬度(LS)和弥散斜率(DS)值分别与病理肝脏纤维化和小叶炎症活动呈正相关关系。

近日,发表Radiology杂志的一项研究评估了在非酒精性脂肪肝患者中使用ATI的ACs和二维SWE的LS及DS值的多参数US的诊断性能,为非酒精性脂肪肝患者病情的无创准确评估提供了技术支持。

项前瞻性研究在2019年12月至2021年6月期间疑似非酒精性脂肪性肝炎(NASH)的患者进行了招募每位参与者均计划在五家三甲医院接受肝脏活检。在手术前,所有参与者根据研究方案进行了ATI和2D SWE US检查。进行多变量线性回归分析以确定AC、LS和DS的重要决定因素。诊断性能是根据受试者工作特性曲线下的面积(AUCs)决定的。

共评估了132名参与者(中位年龄,38岁;IQR,27-54岁;69名女性)。在参与者的特征中,包括病理结果、人口统计学特征、体重指数和血清标志物,其中AC的肝脂肪变性(P < .001)、DS的小叶炎症活动(P = .007),LS的纤维化(P = .01)和小叶炎症活动(P = .04)是重要的决定因素。在组织病理学检查中,132名参与者中有53人(40.2%)患有NASH。与血清标记物或其他US参数(AUC≤0.88)相比,使用AC和DS的分数的未加权总和得到的风险评分系统在检测NASH方面显示出最佳的诊断性能(AUC=0.94;95%CI:0.89,0.98;所有P<0.05)。


 衰减成像的衰减系数、血清丙氨酸氨基转移酶(ALT)水平、二维(2D)剪切波弹性成像(SWE)的剪切波斜率、二维SWE的肝脏硬度值以及多参数US检查的风险评分在组织病理学检查时检测非酒精性脂肪性肝炎的ROC曲线

本研究表明,US成像和二维剪切波弹性成像对评估肝脏脂肪变性、小叶炎症和纤维化具有重要的临床价值。其中,使用衰减系数和弥散斜率得到的风险评分系统对非酒精性脂肪性肝炎显示出最佳的诊断性能。 

原文出处:

Jong Keon Jang,Eun Sun Lee,Jung Wook Seo,et al.Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.DOI:10.1148/radiol.220220

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1956133, encodeId=a986195613329, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84350, encryptionId=8a048435058, topicName=脂肪性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Thu Aug 17 03:52:42 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810240, encodeId=4013181024035, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84349, encryptionId=70f484349b5, topicName=脂肪性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Thu Jun 08 10:52:42 CST 2023, time=2023-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113293, encodeId=0a4d2113293ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69f22463766, createdName=12422320m94暂无昵称, createdTime=Mon Feb 06 22:20:35 CST 2023, time=2023-02-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1673761, encodeId=791116e376157, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Mon Mar 13 13:52:42 CST 2023, time=2023-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676727, encodeId=799416e6727c2, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d18c27357544, createdName=Tommy1958, createdTime=Sun Apr 23 05:52:42 CST 2023, time=2023-04-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1956133, encodeId=a986195613329, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84350, encryptionId=8a048435058, topicName=脂肪性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Thu Aug 17 03:52:42 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810240, encodeId=4013181024035, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84349, encryptionId=70f484349b5, topicName=脂肪性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Thu Jun 08 10:52:42 CST 2023, time=2023-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113293, encodeId=0a4d2113293ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69f22463766, createdName=12422320m94暂无昵称, createdTime=Mon Feb 06 22:20:35 CST 2023, time=2023-02-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1673761, encodeId=791116e376157, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Mon Mar 13 13:52:42 CST 2023, time=2023-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676727, encodeId=799416e6727c2, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d18c27357544, createdName=Tommy1958, createdTime=Sun Apr 23 05:52:42 CST 2023, time=2023-04-23, status=1, ipAttribution=)]
    2023-06-08 qjddjq
  3. [GetPortalCommentsPageByObjectIdResponse(id=1956133, encodeId=a986195613329, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84350, encryptionId=8a048435058, topicName=脂肪性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Thu Aug 17 03:52:42 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810240, encodeId=4013181024035, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84349, encryptionId=70f484349b5, topicName=脂肪性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Thu Jun 08 10:52:42 CST 2023, time=2023-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113293, encodeId=0a4d2113293ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69f22463766, createdName=12422320m94暂无昵称, createdTime=Mon Feb 06 22:20:35 CST 2023, time=2023-02-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1673761, encodeId=791116e376157, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Mon Mar 13 13:52:42 CST 2023, time=2023-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676727, encodeId=799416e6727c2, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d18c27357544, createdName=Tommy1958, createdTime=Sun Apr 23 05:52:42 CST 2023, time=2023-04-23, status=1, ipAttribution=)]
    2023-02-06 12422320m94暂无昵称 来自江苏省

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1956133, encodeId=a986195613329, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84350, encryptionId=8a048435058, topicName=脂肪性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Thu Aug 17 03:52:42 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810240, encodeId=4013181024035, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84349, encryptionId=70f484349b5, topicName=脂肪性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Thu Jun 08 10:52:42 CST 2023, time=2023-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113293, encodeId=0a4d2113293ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69f22463766, createdName=12422320m94暂无昵称, createdTime=Mon Feb 06 22:20:35 CST 2023, time=2023-02-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1673761, encodeId=791116e376157, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Mon Mar 13 13:52:42 CST 2023, time=2023-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676727, encodeId=799416e6727c2, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d18c27357544, createdName=Tommy1958, createdTime=Sun Apr 23 05:52:42 CST 2023, time=2023-04-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1956133, encodeId=a986195613329, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84350, encryptionId=8a048435058, topicName=脂肪性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Thu Aug 17 03:52:42 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810240, encodeId=4013181024035, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84349, encryptionId=70f484349b5, topicName=脂肪性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Thu Jun 08 10:52:42 CST 2023, time=2023-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113293, encodeId=0a4d2113293ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69f22463766, createdName=12422320m94暂无昵称, createdTime=Mon Feb 06 22:20:35 CST 2023, time=2023-02-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1673761, encodeId=791116e376157, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Mon Mar 13 13:52:42 CST 2023, time=2023-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676727, encodeId=799416e6727c2, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d18c27357544, createdName=Tommy1958, createdTime=Sun Apr 23 05:52:42 CST 2023, time=2023-04-23, status=1, ipAttribution=)]

相关资讯

Clin Gastroenterology H: PNPLA3多态性降低了非酒精性脂肪肝患者患糖尿病的易感性

非酒精性脂肪性肝病(NAFLD)是指除外酒精和其他明确的损肝因素所致的肝细胞内脂肪过度沉积为主要特征的临床病理综合征,与胰岛素抵抗和遗传易感性密切相关的获得性代谢应激性肝损伤。

FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格

2022年5月26日,辉瑞宣布FDA已授予辉瑞(Pfizer) 研究性组合疗法Ervogastat / Clesacostat用于治疗非酒精性脂肪性肝炎 (NASH) 合并肝纤维化的快速通道资格。其中

Nature Communications:为何女性不易患非酒精性脂肪性肝炎?

这是针对NAFLD/NASH的更深入了解的开始,也是朝着有效的基于性别的疗法迈出的第一步。

Eur Heart J:复方丸预防心血管疾病,重点是非酒精性脂肪性肝炎

在接受固定剂量联合治疗的患者中,复方丸可安全有效地预防MCVE,即使在脂肪肝和肝酶升高的参与者中也是如此。

仅30年,这种肝炎相关的肝癌发病率已翻倍!(不是乙肝)

Diabetol Metab Syndr:全球非酒精性脂肪性肝炎相关肝癌负担,1990-2019:GBD 2019的系统分析。

Hepatology:非酒精性脂肪性肝炎的潜在治疗新靶点被发现

该研究结果表明,mPGES-2 可能是肝脂肪变性和 NASH 的新治疗靶点。

Baidu
map
Baidu
map
Baidu
map